VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Willing and capable of providing informed consent  │ Willing and capable of providing informed consent  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has an indication for implantation of a single or  │ Has an indication for implantation of a single or  │     100 │
│ dual chamber ICD or CRT-D system in their          │ dual chamber ICD or CRT-D system in their          │         │
│ respective geography                               │ respective geography                               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subjects planned to be implanted with the RELIANCE │ Subjects planned to be implanted with the RELIANCE │     100 │
│ 4-FRONT Passive Fixation Lead                      │ 4-FRONT Passive Fixation Lead                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Willing and capable of participating in all        │ Willing and capable of participating in all        │     100 │
│ testing/ visits associated with this clinical      │ testing/ visits associated with this clinical      │         │
│ study at an approved clinical study center and at  │ study at an approved clinical study center and at  │         │
│ the intervals defined by this protocol             │ the intervals defined by this protocol             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Age 18 or above, or of legal age to give informed  │ Age 18 or above, or of legal age to give informed  │     100 │
│ consent specific to state and national law         │ consent specific to state and national law         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Known or suspected sensitivity to Dexamethasone    │ Known or suspected sensitivity to Dexamethasone    │     100 │
│ Acetate (DXA)                                      │ Acetate (DXA)                                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Mechanical tricuspid heart valve                   │ Mechanical tricuspid heart valve                   │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject is enrolled in any other concurrent study  │ Subject is enrolled in any other concurrent study  │     100 │
│ without prior written approval from Boston         │ without prior written approval from Boston         │         │
│ Scientific (BSC), with the exception of local      │ Scientific (BSC), with the exception of local      │         │
│ mandatory governmental registries and              │ mandatory governmental registries and              │         │
│ observational studies/registries that are not in   │ observational studies/registries that are not in   │         │
│ conflict and do not affect the following           │ conflict and do not affect the following           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Schedule of procedures for the RELIANCE 4-Front    │ Schedule of procedures for the RELIANCE 4-Front    │     100 │
│ Study (i.e. should not cause additional or missed  │ Study (i.e. should not cause additional or missed  │         │
│ visits)                                            │ visits)                                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ RELIANCE 4-Front Study outcome (i.e. involve       │ RELIANCE 4-Front Study outcome (i.e. involve       │     100 │
│ medications that could affect the heart rate of    │ medications that could affect the heart rate of    │         │
│ the subject)                                       │ the subject)                                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Conduct of the RELIANCE 4-Front Study per Good     │ Conduct of the RELIANCE 4-Front Study per Good     │     100 │
│ Clinical Practice (GCP)/ International             │ Clinical Practice (GCP)/ International             │         │
│ Organization for Standardization (ISO) 14155:2011/ │ Organization for Standardization (ISO) 14155:2011/ │         │
│ 21 CFR 812/ local regulations                      │ 21 CFR 812/ local regulations                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Currently on the active heart transplant list      │ Currently on the active heart transplant list      │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Documented life expectancy of less than 12 months  │ Documented life expectancy of less than 12 months  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Women of childbearing potential who are or might   │ Women of childbearing potential who are or might   │     100 │
│ be pregnant at the time of study enrollment        │ be pregnant at the time of study enrollment        │         │
│ (method of assessment upon physician discretion)   │ (method of assessment upon physician discretion)   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Currently requiring chronic dialysis               │ Currently requiring chronic dialysis               │     100 │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤══════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                        │   Score │
╞═══════════════════════════════════╪══════════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ Currently requiring chronic dialysis │      35 │
╘═══════════════════════════════════╧══════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 99
Average Levenshtein Ratio of individual lines: 95.9375
OverAll Ratio: 97.46875
